Search

Your search keyword '"A. Kran"' showing total 848 results

Search Constraints

Start Over You searched for: Author "A. Kran" Remove constraint Author: "A. Kran"
848 results on '"A. Kran"'

Search Results

1. Multi-Agent Security Tax: Trading Off Security and Collaboration Capabilities in Multi-Agent Systems

2. Multi-Agent Risks from Advanced AI

3. Benchmark Inflation: Revealing LLM Performance Gaps Using Retro-Holdouts

4. Catastrophic Cyber Capabilities Benchmark (3CB): Robustly Evaluating LLM Agent Cyber Offense Capabilities

5. DeepDecipher: Accessing and Investigating Neuron Activation in Large Language Models

7. Characterization of the SARS-CoV-2 antibody landscape in Norway in the late summer of 2022: high seroprevalence in all age groups with patterns of primary Omicron infection in children and hybrid immunity in adults

9. Neuron to Graph: Interpreting Language Model Neurons at Scale

10. Detecting Edit Failures In Large Language Models: An Improved Specificity Benchmark

11. N2G: A Scalable Approach for Quantifying Interpretable Neuron Representations in Large Language Models

12. Desorption isotherms and thermodynamic properties of 'Solanum gilo'

13. Special Commentary: Cerebral/Cortical Visual Impairment Working Definition: A Report from the National Institutes of Health CVI Workshop

14. List of contributors

23. Anti-inflammatory effects of moxifloxacin and levofloxacin on cadmium-activated human astrocytes: Inhibition of proinflammatory cytokine release, TLR4/STAT3, and ERK/NF-κB signaling pathway.

34. Strategies to Inform Our Current and Future Understanding of CVI: A Multinational and Multidisciplinary Commentary.

35. Artificial Intelligence and Privacy:Causes for Concern

36. Clinical trial:An open-label, randomised trial of different re-start strategies after treatment withdrawal in HBeAg negative chronic hepatitis B

38. Discovery of survival factor for primitive chronic myeloid leukemia cells using induced pluripotent stem cells

42. Induced Pluripotent Stem Cell Model of Chronic Myeloid Leukemia Revealed Olfactomedin 4 As a Novel Survival Factor for Primitive Leukemia Cells

43. Clinical trial: An open‐label, randomised trial of different re‐start strategies after treatment withdrawal in HBeAg negative chronic hepatitis B.

Catalog

Books, media, physical & digital resources